Baseline representativeness of patients in clinics enrolled in the PRimary care Opioid Use Disorders treatment (PROUD) trial: comparison of trial and non-trial clinics …
PD Wartko, H Qiu, AE Idu, O Yu, J McCormack… - BMC health services …, 2022 - Springer
Background Pragmatic primary care trials aim to test interventions in “real world” health care
settings, but clinics willing and able to participate in trials may not be representative of …
settings, but clinics willing and able to participate in trials may not be representative of …
PRimary Care Opioid Use Disorders treatment (PROUD) trial protocol: a pragmatic, cluster-randomized implementation trial in primary care for opioid use disorder …
CI Campbell, AJ Saxon, DM Boudreau… - Addiction science & …, 2021 - Springer
Background Most people with opioid use disorder (OUD) never receive treatment.
Medication treatment of OUD in primary care is recommended as an approach to increase …
Medication treatment of OUD in primary care is recommended as an approach to increase …
The medications for opioid use disorder study: methods and initial outcomes from an 18-month study of patients in treatment for opioid use disorder
JA Dever, MF Hertz, LJ Dunlap… - Public Health …, 2024 - journals.sagepub.com
Objective: Opioid use disorder (OUD) affects approximately 5.6 million people in the United
States annually, yet rates of the use of effective medication for OUD (MOUD) treatment are …
States annually, yet rates of the use of effective medication for OUD (MOUD) treatment are …
Nurse care management for opioid use disorder treatment: the PROUD cluster randomized clinical trial
PD Wartko, JF Bobb, DM Boudreau… - JAMA internal …, 2023 - jamanetwork.com
Importance Few primary care (PC) practices treat patients with medications for opioid use
disorder (OUD) despite availability of effective treatments. Objective To assess whether …
disorder (OUD) despite availability of effective treatments. Objective To assess whether …
Comparative effectiveness of different treatment pathways for opioid use disorder
Importance Although clinical trials demonstrate the superior effectiveness of medication for
opioid use disorder (MOUD) compared with nonpharmacologic treatment, national data on …
opioid use disorder (MOUD) compared with nonpharmacologic treatment, national data on …
Offering nurse care management for opioid use disorder in primary care: Impact on emergency and hospital utilization in a cluster-randomized implementation trial
Background Patients with opioid use disorder (OUD) have increased emergency and
hospital utilization. The PROUD trial showed that implementation of office-based addiction …
hospital utilization. The PROUD trial showed that implementation of office-based addiction …
[HTML][HTML] An international comparative policy analysis of opioid use disorder treatment in primary care across nine high-income jurisdictions
Background Opioid use disorder (OUD) and opioid-related harms are current health
priorities in many high-income countries such as Canada. Opioid agonist therapy (OAT) is …
priorities in many high-income countries such as Canada. Opioid agonist therapy (OAT) is …
Comparison of rates of overdose and hospitalization after initiation of medication for opioid use disorder in the inpatient vs outpatient setting
Importance Whereas outpatient treatment with medication for opioid use disorder (MOUD) is
evidence based, there is a large network of inpatient facilities in the US that are reimbursed …
evidence based, there is a large network of inpatient facilities in the US that are reimbursed …
Outpatient care for opioid use disorder among the commercially insured: Use of medication and psychosocial treatment
AB Busch, SF Greenfield, S Reif, SLT Normand… - Journal of substance …, 2020 - Elsevier
Background Evidence-based outpatient treatment for opioid use disorder (OUD) consists of
medications that treat OUD (MOUD) and psychosocial treatments (eg, psychotherapy or …
medications that treat OUD (MOUD) and psychosocial treatments (eg, psychotherapy or …
[HTML][HTML] Under-representation of key demographic groups in opioid use disorder trials
KE Rudolph, M Russell, SX Luo, J Rotrosen… - Drug and alcohol …, 2022 - Elsevier
Background The extent to which clinical trials of medications for opioid use disorder (MOUD)
are representative or not is unknown. Some patient characteristics modify MOUD …
are representative or not is unknown. Some patient characteristics modify MOUD …